✦ LIBER ✦

Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus

✍ Scribed by Ning-fu Peng; Le-qun Li; Xiao Qin; Ya Guo; Tao Peng; Kai-yin Xiao; Xi-gang Chen; Yu-feng Yang; Zhi-xiong Su; Bin Chen; Ming Su; Lu-nan Qi

Book ID: 111773957
Publisher: Springer
Year: 2011
Tongue: English
Weight: 316 KB
Volume: 18
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-010-1458-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for intrahepatic cholangioc

Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus

✍ M. Tanaka; H. Tanaka; H. Tsukuma; A. Ioka; A. Oshima; T. Nakahara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Prevalence, risk factors and evaluation

Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees

✍ V. Sypsa; E. Hadjipaschali; A. Hatzakis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 94 KB

Lamivudine and low-dose hepatitis B immu

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation – possible role of mutations in the YMDD motif prior totransplantation as a risk factor for reinfection

✍ Jens Rosenau; Matthias J. Bahr; Hans L. Tillmann; Christian Trautwein; Jürgen Kl 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Risk factors for hepatitis B virus infec

Risk factors for hepatitis B virus infection among heterosexuals attending a sexually transmitted diseases clinic in Italy: Role of genital ulcerative diseases

✍ Corona, Rosamaria; Caprilli, Federico; Giglio, Amalia; Stroffolini, Tommaso; Tos 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 2 views

The seroprevalence and risk factors for hepatitis B virus (HBV) infection were determined among 1,497 heterosexuals with no history of intravenous drug use (median age 32, range 15-78) treated at a sexually transmitted disease clinic in Rome. A total of 329 (22.0%) had antibodies to HBV core antigen